Mutational diversity of NS5A and NS3 during triple therapy (telaprevir, pegylated-interferon-α 2b and ribavirin) for genotype 1b chronic hepatitis C: The Kobe Hepatitis Therapeutic Group.
暂无分享，去创建一个
H. Hotta | T. Azuma | Y. Seo | Y. Yano | Y. Hayashi | A. Miki | S. Kim | A. Minami | M. Sugano | M. Saito | T. Hayakumo | S. Tani | S. Imoto | F. Bai | H. Hirano | K. Momose | Yuri Hatazawa | D. I. Widasari | H. Rinonce | Seitetsu Yoon